99% Savings - Buy Just @1 Rs X
Atorvastatin + Fenofibrate + Ezetimibe is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Atorvastatin + Fenofibrate + Ezetimibe safe for pregnant women?
Side effects of Atorvastatin + Fenofibrate + Ezetimibe during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Atorvastatin + Fenofibrate + Ezetimibe safe during breastfeeding?
Atorvastatin + Fenofibrate + Ezetimibe may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Atorvastatin + Fenofibrate + Ezetimibe, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Atorvastatin + Fenofibrate + Ezetimibe.
What is the effect of Atorvastatin + Fenofibrate + Ezetimibe on the Kidneys?
Atorvastatin + Fenofibrate + Ezetimibe can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Atorvastatin + Fenofibrate + Ezetimibe on the Liver?
Atorvastatin + Fenofibrate + Ezetimibe may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Atorvastatin + Fenofibrate + Ezetimibe on the Heart?
Side effects of Atorvastatin + Fenofibrate + Ezetimibe rarely affect the heart.
Atorvastatin + Fenofibrate + Ezetimibe should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Atorvastatin + Fenofibrate + Ezetimibe unless your doctor advises you to do so -
Is this Atorvastatin + Fenofibrate + Ezetimibe habit forming or addictive?
Forming a habit of Atorvastatin + Fenofibrate + Ezetimibe has not been reported.
Interaction between Food and Atorvastatin + Fenofibrate + Ezetimibe
Taking Atorvastatin + Fenofibrate + Ezetimibe with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Atorvastatin + Fenofibrate + Ezetimibe
Information about the interaction of Atorvastatin + Fenofibrate + Ezetimibe and alcohol is not currently available because this topic has not been researched yet.
No, Atorvastatin + Fenofibrate + Ezetimibe should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Atorvastatin + Fenofibrate + Ezetimibe might cause hair loss but it occurs very rarely. This problem goes away after discontinuation of the drug. However, if you notice excessive hair loss then consult it with your doctor.
It has been reported to cause weight gain but only in a few cases, this occurs very rarely. However, the exact cause behind this is unknown. if you notice any unusual weight gain after taking this drug. Then you are recommended to discuss it with your doctor.
No, use of Atorvastatin + Fenofibrate + Ezetimibe does not cause memory loss in the patients who are taking it. It has not been reported to cause memory loss.
Atorvastatin + Fenofibrate + Ezetimibe comes in form of a tablet and ideally, it should be taken by mouth once daily as advised by your doctor. It can be taken with food or without food at any time of the day. Precautions must be taken in patients with liver disease, diabetes, and hypothyroidism.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zetia® (ezetimibe)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 641
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 545-546